Drug Profile
Beta cell therapy - Beta-Cell
Alternative Names: BetaGraft; BetaGraft1.0Latest Information Update: 12 Sep 2023
Price :
$50
*
At a glance
- Originator Beta-Cell
- Class Cell therapies
- Mechanism of Action Pancreatic beta cell replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Diabetes mellitus
Most Recent Events
- 12 Sep 2023 Beta cell therapy is still in preclinical development for Diabetes-mellitus in Belgium (Parenteral, Injection) (Beta-Cell pipeline, September 2023)
- 28 Aug 2020 No recent reports of development identified for preclinical development in Diabetes-mellitus in Belgium (Parenteral, Injection)
- 27 Jul 2016 Preclinical trials in Diabetes mellitus in Belgium (Parenteral)